Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Chromosome 9 open reading frame 72 (C9orf72) G4C2 sense repeat RNA transcripts are pathological RNA species generated from the hexanucleotide repeat expansion (HRE) in the first intron of the C9orf72 gene [1, 8]. This expansion, typically consisting of hundreds to thousands of GGGGCC repeats, is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) [3, 10]. These sense transcripts fold into complex secondary structures, such as G-quadruplexes and hairpins, which aggregate into nuclear RNA foci and sequester essential RNA-binding proteins, thereby disrupting RNA processing and nucleocytoplasmic transport [1, 12]. Furthermore, the transcripts serve as templates for repeat-associated non-AUG (RAN) translation, producing toxic dipeptide repeat proteins (DPRs) like poly-GA, poly-GR, and poly-GP that aggregate in the brains of affected individuals [3, 15]. Therapeutic efforts have largely focused on using antisense oligonucleotides (ASOs) and RNA interference to selectively degrade these toxic transcripts or block their translation [3, 14]. However, recent clinical trial failures of major ASO candidates like BIIB078 and WVE-004 have highlighted the complexity of the disease, suggesting that both gain-of-toxicity from RNA/DPRs and loss-of-function from reduced C9orf72 protein levels may contribute to pathogenesis [21, 24].
RNase H-mediated degradation of repeat-containing RNA and steric blocking of RNA-binding protein sequestration and RAN translation [3, 14].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 9 open reading frame 72 G4C2 sense repeat RNA transcripts (C9orf72 HRE sense RNA).